We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Dr. Ignacio Asial is the Founder and CEO of DotBio. He designed and conceptualized the DotBody technology based on his expertise in protein and antibody engineering at NTU’s School of Biological Sciences. Previous to launching DotBio, Dr. Asial worked both in the private (Genentech USA, Ambrilia France) and public (CNRS France, NTU Singapore, UCSF USA) sectors.
This speaker's sessions: